Abstract
Type 2 diabetes disproportionately affects socially disadvantaged groups, including racial and ethnic minority groups and low income and less educated persons [1-7]. Although effective therapies are available for managing diabetes and preventing or treating its complications, these therapies are underutilized, particularly among these socially disadvantaged groups [8-10]. Social disadvantage may affect diabetes outcomes through a number of different pathways, including access to care, the quality of care received, psychosocial characteristics, and neighborhood or community factors [11]. Because of the high prevalence of diabetes in socially disadvantaged persons, interventions to reduce racial/ethnic and social disparities in health may have a profound impact on the morbidity and mortality associated with diabetes. In this review, we will discuss evidence on interventions at the individual, provider, health care system, and community levels that have the potential to reduce diabetes disparities and highlight gaps in our understanding of social disparities and health for persons with diabetes.
Keywords: Social Support, interventions, LDL, neighborhood level, health care system
Current Diabetes Reviews
Title: Patient, System and Clinician Level Interventions to Address Disparities in Diabetes Care
Volume: 3 Issue: 4
Author(s): Arleen F. Brown
Affiliation:
Keywords: Social Support, interventions, LDL, neighborhood level, health care system
Abstract: Type 2 diabetes disproportionately affects socially disadvantaged groups, including racial and ethnic minority groups and low income and less educated persons [1-7]. Although effective therapies are available for managing diabetes and preventing or treating its complications, these therapies are underutilized, particularly among these socially disadvantaged groups [8-10]. Social disadvantage may affect diabetes outcomes through a number of different pathways, including access to care, the quality of care received, psychosocial characteristics, and neighborhood or community factors [11]. Because of the high prevalence of diabetes in socially disadvantaged persons, interventions to reduce racial/ethnic and social disparities in health may have a profound impact on the morbidity and mortality associated with diabetes. In this review, we will discuss evidence on interventions at the individual, provider, health care system, and community levels that have the potential to reduce diabetes disparities and highlight gaps in our understanding of social disparities and health for persons with diabetes.
Export Options
About this article
Cite this article as:
Brown F. Arleen, Patient, System and Clinician Level Interventions to Address Disparities in Diabetes Care, Current Diabetes Reviews 2007; 3 (4) . https://dx.doi.org/10.2174/157339907782329988
DOI https://dx.doi.org/10.2174/157339907782329988 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Islet Amyloid Polypeptide (IAPP): A Second Amyloid in Alzheimer's Disease
Current Alzheimer Research Pioglitazone and Cancer: Angel or Demon?
Current Pharmaceutical Design Calpains: Attractive Targets for the Development of Synthetic Inhibitors
Current Topics in Medicinal Chemistry Type I Interferon as a Target of Treatment in SLE
Endocrine, Metabolic & Immune Disorders - Drug Targets The Multidomain Mobility Lab in Older Persons: From Bench to Bedside. The Assessment of Body Composition in Older Persons at Risk of Mobility Limitations
Current Pharmaceutical Design Anti-platelet Drug-loaded Targeted Technologies for the Effective Treatment of Atherothrombosis
Current Drug Targets Best Practice for Atrial Fibrillation Patient Education
Current Pharmaceutical Design Vaginal Birth After Cesarean: How to Counsel Patients Using the Evidence
Current Women`s Health Reviews Ambulatory Blood Pressure Monitoring in the Diagnosis and Management of Arterial Hypertension in Current Medical Practice in Algeria
Current Hypertension Reviews Collagen Cross-link Breakers:A Beginning of a New Era in the Treatment of Cardiovascular Changes Associated with Aging,Diabetes,and Hypertension
Current Drug Targets - Cardiovascular & Hematological Disorders Angiotensin Converting Enzyme (ACE) Inhibitory Peptides: Production and Implementation of Functional Food
Current Pharmaceutical Design Triglycerides and Cardiovascular Risk
Current Cardiology Reviews Oxidative Stress in Polycystic Ovary Syndrome
Current Pharmaceutical Design Pathogens and Chronic or Long-Term Neurologic Disorders
Cardiovascular & Hematological Disorders-Drug Targets Hydroethanolic Extract of <i>Lampaya Medicinalis</i> Phil. (<i>Verbenaceae</i>) Decreases Proinflammatory Marker Expression in Palmitic Acid-exposed Macrophages
Endocrine, Metabolic & Immune Disorders - Drug Targets Endothelial Progenitor Cells as Potential Drug Targets
Current Drug Targets - Cardiovascular & Hematological Disorders Fenofibrate, Homocysteine and Renal Function
Current Vascular Pharmacology Pleiotropic Effects of Nicotinic Acid: Beyond High Density Lipoprotein Cholesterol Elevation
Current Vascular Pharmacology Nicotinamide: Oversight of Metabolic Dysfunction Through SIRT1, mTOR, and Clock Genes
Current Neurovascular Research Sulfonyl Group-Containing Compounds in the Design of Potential Drugs for the Treatment of Diabetes and Its Complications
Current Medicinal Chemistry